Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Biotech Startup Raises $175 Million to Advance Alzheimer’s Antibody Therapy

Summary by STAT
Biotech startup believes its "brain shuttles" could offer advantages over existing treatments like Leqembi and Kisunla.

2 Articles

STATSTAT
Center

Biotech startup raises $175 million to advance Alzheimer’s antibody therapy

Biotech startup believes its "brain shuttles" could offer advantages over existing treatments like Leqembi and Kisunla.

·Boston, United States
Read Full Article
Voice of AlexandriaVoice of Alexandria

Korsana Biosciences Emerges from Stealth with $175 Millon in Funding to Advance Potential Best-in-Class Therapeutics for Neurodegenerative Diseases

WALTHAM, Mass.--(BUSINESS WIRE)--Feb 18, 2026-

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

STAT broke the news in Boston, United States on Wednesday, February 18, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Alzheimer's Disease icon

Alzheimer's Disease

Waltham, Massachusetts icon

Waltham, Massachusetts

Health & Medicine icon

Health & Medicine

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal